|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1986-4-14
|
|
pubmed:abstractText |
This report describes a patient treated for lymphoma who had development of doxorubicin (Adriamycin) cardiotoxicity proved by endomyocardial biopsy seven years after treatment. Doxorubicin cardiotoxicity is reviewed with emphasis on the implications of the long latency period for anthracycline cardiotoxicity in patients treated with this widely used antineoplastic agent.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
483-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3513562-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3513562-Biopsy,
pubmed-meshheading:3513562-Cyclophosphamide,
pubmed-meshheading:3513562-Doxorubicin,
pubmed-meshheading:3513562-Endocardium,
pubmed-meshheading:3513562-Female,
pubmed-meshheading:3513562-Heart Failure,
pubmed-meshheading:3513562-Humans,
pubmed-meshheading:3513562-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:3513562-Middle Aged,
pubmed-meshheading:3513562-Myocardium,
pubmed-meshheading:3513562-Prednisone,
pubmed-meshheading:3513562-Vincristine
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
